Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception

Eur J Pharmacol. 1999 May 7;372(1):25-30. doi: 10.1016/s0014-2999(99)00181-8.

Abstract

We investigated the role of mu-opioid receptor subtypes in both endomorphin-1 and endomorphin-2 induced antinociception in mice using supraspinally mediated behavior. With tail pressure as a mechanical noxious stimulus, both intracerebroventricularly (i.c.v.) and intrathecally (i.t.) injected-endomorphins produced potent and significant antinociceptive activity. Antinociception induced by i.t. and i.c.v. injection of endomorphin-1 was not reversed by pretreatment with a selective mu1-opioid receptor antagonist, naloxonazine (35 mg/kg, s.c.). By contrast, antinociception induced by i.t. and i.c.v. endomorphin-2 was significantly decreased by mu1-opioid receptor antagonist. Antinociception of both i.t. and i.c.v. endomorphin-1 and -2 was completely reversed by pretreatment with beta-funaltrexamine (40 mg/kg, s.c.). The results indicate that endomorphins may produce antinociception through the distinct mu1 and mu2 subtypes of mu-opioid receptor.

Publication types

  • Comparative Study

MeSH terms

  • Analgesics, Opioid / pharmacology*
  • Animals
  • Dose-Response Relationship, Drug
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • Enkephalins / pharmacology
  • Injections, Intraventricular
  • Injections, Spinal
  • Male
  • Mice
  • Naloxone / analogs & derivatives
  • Naloxone / pharmacology
  • Naltrexone / analogs & derivatives
  • Naltrexone / pharmacology
  • Narcotic Antagonists / pharmacology
  • Nociceptors / drug effects*
  • Oligopeptides / pharmacology*
  • Pain / physiopathology
  • Pain / prevention & control
  • Receptors, Opioid, mu / agonists
  • Receptors, Opioid, mu / physiology*
  • Time Factors

Substances

  • Analgesics, Opioid
  • Enkephalins
  • Narcotic Antagonists
  • Oligopeptides
  • Receptors, Opioid, mu
  • endomorphin 1
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • Naloxone
  • endomorphin 2
  • Naltrexone
  • beta-funaltrexamine
  • naloxonazine